UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform
Zai Lab Limited (NASDAQ:ZLAB) ranks among the best high growth Chinese stocks to buy.
Zai Lab Ltd (ZLAB)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Walleye Capital Will England | 373,399 | $6,586,758 | 0.02% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 231,802 | $4,088,987 | +278% | 0% |
| 3. | Hudson Bay Capital Management Sander Gerber | 90,000 | $1,587,600 | 0.01% | |
| 4. | Long Corridor Asset Management James Xinjun Tu | 65,800 | $1,160,712 | 0.08% | |
| 5. | IvyRock Asset Management Charles Huang | 14,979 | $264,230 | -85% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.91 | 10,000 | $289,100.00 | 86,604 | 2025-09-10 | Filing | |
| $21.40 | 3,000 | $64,200.00 | 31,684 | 2024-05-13 | Filing | |
| $20.83 | 3,000 | $62,490.00 | 23,527 | 2024-03-01 | Filing | |
| $29.90 | 4,000 | $119,600.00 | 20,527 | 2023-12-14 | Filing | |
| $26.93 | 5,000 | $134,650.00 | 16,527 | 2023-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.43 | 10,787 | $188,038.98 | 52,391 | 2025-12-31 | Filing | |
| $17.14 | 8,651 | $148,278.14 | 19,086 | 2025-12-16 | Filing | |
| $19.78 | 14,328 | $283,407.84 | 27,737 | 2025-11-21 | Filing | |
| $26.83 | 240 | $6,439.44 | 17,444 | 2025-11-03 | Filing | |
| $34.25 | 456 | $15,616.63 | 17,184 | 2025-10-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,902,320 | $33,556,925 | 0.9% | |
| 2. | 1,808,035 | $31,893,740 | 0.03% | |
| 3. | 1,782,252 | $31,438,925 | 0.01% | |
| 4. | 635,213 | $11,205,157 | 0% | |
| 5. | 387,800 | $6,842,649 | 0% |
News See All
8 High Growth Chinese Stocks To Buy
China's stock market boom is attracting heightened attention from regulators after trading activity reached record highs, causing officials to take steps to limit leverage, even though a number of investors...
12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum
As of November 27, Zai Lab Limited (NASDAQ:ZLAB) is a consensus Buy with over 90% analysts covering it having a Buy, Strong Buy, or equivalent rating.
12 Oversold Global Stocks to Invest In
Appearing in an interview with CNBC on November 21, 2025, David Katz of Matrix Asset Advisors called widespread weakness a potential entry point, saying that the current correction is “much closer to...
Zai Lab Limited (NASDAQ:ZLAB) Q3 2025 Earnings Call Transcript
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Third Quarter 2025 Financial Results Conference Call. [Operator Instructions].
Zai Lab Limited (ZLAB): A Bull Case Theory
We came across a bullish thesis on Zai Lab Limited on Value investing subreddit by mrmrmrj. In this article, we will summarize the bulls’ thesis on ZLAB.
Zai Lab Limited (NASDAQ:ZLAB) Q2 2025 Earnings Call Transcript
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Second Quarter 2025 Financial Results Conference Call.
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment
Zai Lab Ltd (NASDAQ:ZLAB) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On June 30, Leerink Partners raised its price target for the stock to $75 from $73.
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen
Steve Cohen, whose success at SAC Capital made him one of the most successful hedge fund managers on Wall Street, is a worried man.
Hedge Fund Resource Center Billionaire Hedge Funds
